• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    55 Biggest Movers From Friday

    4/25/22 4:23:55 AM ET
    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALVR alert in real time by email

    Gainers

    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate strategic alternatives for the Company to maximize shareholder value.
    • Blueknight Energy Partners, L.P. (NASDAQ:BKEP) shares gained 38.6% to close at $4.56 on Friday after the company announced it will be acquired by its general partner Ergon.
    • Moving iMage Technologies, Inc. (NASDAQ:MITQ) gained 38.3% to close at $1.59. Moving iMage Technologies and SNDBX reported a strategic partnership for gaming and e-Sports.
    • Cyngn Inc. (NASDAQ:CYN) gained 26.9% to settle at $2.69. Cyngn recently announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.
    • Sky Harbour Group Corporation (NYSE:SKYH) jumped 26.3% to close at $8.01 on abnormally-high volume.
    • Forge Global Holdings, Inc. (NYSE:FRGE) gained 20% to settle at $14.04 on below-average volume.
    • Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) rose 18.6% to close at $1.21.
    • DURECT Corporation (NASDAQ:DRRX) jumped 15.6% to settle at $0.4739.
    • Evelo Biosciences, Inc. (NASDAQ:EVLO) rose 15.3% to close at $2.41. Evelo Biosciences recently said it will put the EDP1867 program on hold after completing a Phase 1 clinical trial in atopic dermatitis.
    • GWG Holdings, Inc. (NASDAQ:GWGH) gained 15% to settle at $2.30.
    • Amryt Pharma plc (NASDAQ:AMYT) jumped 14.6% to close at $8.87 after the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the approval of Filsuvez in the European Union for the treatment of epidermolysis bullosa.
    • Ampio Pharmaceuticals, Inc. (NYSE:AMPE) rose 13.6% to close at $0.2815. Ampio Pharmaceuticals shares dropped 27% on Thursday after the company provided a regulatory update and said the FDA did not agree with the company's proposed changes to its AP-013 trial.
    • Harbor Custom Development, Inc. (NASDAQ:HCDI) rose 13% to settle at $2.53. Harbor Custom Development recently restated its earnings.
    • Gelesis Holdings, Inc. (NYSE:GLS) jumped 12.9% to close at $4.90 on below-average volume.
    • FAT Brands Inc. (NASDAQ:FAT) gained 11.7% to close at $6.13.
    • Chindata Group Holdings Limited (NASDAQ:CD) shares gained 9.8% to close at $4.81 after Bloomberg reported the company had received early takeover interest from other companies in the industry.
    • A10 Networks, Inc. (NYSE:ATEN) gained 9.4% to close at $14.44 after it was announced the company is set to join the S&P SmallCap 600.
    • Kimberly-Clark Corporation (NYSE:KMB) jumped 8.1% to settle at $138.51 after the company reported better-than-expected Q1 adjusted EPS and sales results.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) gained 8% to close at $41.00 after dropping over 17% on Thursday.
    • SVB Financial Group (NASDAQ:SIVB) gained 7.5% to close at $541.04 after the company reported better-than-expected Q1 EPS results and raised its FY22 revenue guidance.

     

    Losers

    • Babylon Holdings Limited (NYSE:BBLN) shares tumbled 52.7% to close at $1.75 on Friday. The company is scheduled to report Q1 results on May 12, 2022.
    • Dogness (International) Corporation (NASDAQ:DOGZ) dipped 46% to settle at $3.51.
    • ION Geophysical Corporation (NYSE:IO) shares tumbled 27.9% to close at $0.4703. ION Geophysical recently announced it has been awarded a five-year contract by Brunei Shell Petroleum for a digital solution to manage Marine Logistics.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) fell 27.5% to close at $8.55.
    • FedNat Holding Company (NASDAQ:FNHC) fell 26.5% to close at $0.5345 on continued weakness following Thursday comments from Fed Chair Powell suggesting a rate hike of 50 basis points is possible for May.
    • SCYNEXIS, Inc. (NASDAQ:SCYX) dipped 25.8% to close at $2.33. SCYNEXIS announced interim data from its ongoing Phase 3 FURI and CARES studies of ibrexafungerp in severe fungal infections. The company also reported pricing of $45 million public offering of common stock, pre-funded warrants and warrants.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) fell 25.7% to close at $3.18. Pulse BioSciences recently reported rights offering for $15 million in units.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) fell 22.1% to close at $1.80 after gaining 11% on Thursday. The company on Tuesday announced it will present new data on JATENZO at the Androgen Society 4th Annual Meeting.
    • HCA Healthcare, Inc. (NYSE:HCA) fell 21.8% to close at $210.64 after the company reported worse-than-expected Q1 adjusted EPS results and cut FY22 guidance.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) dropped 20.5% to close at $0.2701 after the company announced a $2.3 million registered direct offering.
    • NACCO Industries, Inc. (NYSE:NC) fell 19.4% to settle at $40.00.
    • Onion Global Limited (NYSE:OG) dipped 19.3% to close at $1.51.
    • Value Line, Inc. (NASDAQ:VALU) dipped 19.2% to close at $61.70.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) fell 19% to settle at $2.09.
    • Cuentas Inc. (NASDAQ:CUEN) fell 18.6% to close at $1.01.
    • The Gap, Inc. (NYSE:GPS) fell 18% to close at $11.72 after the company said Nancy Green, CEO and president of its largest brand, Old Navy, is departing this week. Gap also lowered its quarterly forecast.
    • Community Health Systems, Inc. (NYSE:CYH) fell 17.9% to close at $9.43.
    • SciSparc Ltd. (NASDAQ:SPRC) dropped 17.7% to settle at $2.70 on below-average volume.
    • Surgery Partners, Inc. (NASDAQ:SGRY) declined 16.7% to close at $50.12.
    • AlloVir, Inc. (NASDAQ:ALVR) fell 16.6% to close at $4.52. AlloVir recently announced the FDA granted Regenerative Medicine Advanced Therapy designation to its posoleuce for the prevention of infections from six viruses in allogeneic hematopoietic cell transplant patients.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) dipped 16% to close at $0.7430. Plus Therapeutics recently posted Q1 loss of $0.19 per share.
    • Tenet Healthcare Corporation (NYSE:THC) dropped 15.7% to close at $73.11. Tenet Healthcare recently said Q1 FY22 adjusted EPS came in at $1.93, up from $1.30 a year ago and beating the management guidance of $0.92 - $1.15.
    • Sharps Technology, Inc. (NASDAQ:STSS) fell 14.8% to close at $1.49.
    • Global Internet of People, Inc. (NASDAQ:SDH) dipped 14.7% to settle at $2.03.
    • Intuitive Surgical, Inc. (NASDAQ:ISRG) fell 14.3% to close at $252.34 after the company reported Q1 earnings results.
    • Universal Health Services, Inc. (NYSE:UHS) dipped 14% to close at $132.93 ahead of quarterly earnings.
    • Sientra, Inc. (NASDAQ:SIEN) fell 13.9% to settle at $1.42.
    • Lantronix, Inc. (NASDAQ:LTRX) dipped 14.2% to close at $5.52.
    • Locafy Limited (NASDAQ:LCFY) dropped 13.4% to settle at $1.23.
    • Globus Medical, Inc. (NYSE:GMED) fell 13.3% to close at $68.53. Globus Medical announced the resignation of President and CEO Dave Demski after nearly 20 years with the company, with the last four and a half years as its CEO. The company also expects Q1 FY22 sales of approximately $230.5 million, up 1.4% Y/Y, compared to the consensus of $235.94 million.
    • Corsair Gaming, Inc. (NASDAQ:CRSR) shares fell 11.8% to close at $16.15 after the company issued Q1 revenue guidance below analyst estimates.
    • Herc Holdings Inc. (NYSE:HRI) fell 10.5% to close at $132.02. The company recently posted mixed quarterly results.
    • Lands' End, Inc. (NYSE:LE) fell 9.3% to close at $14.51 after Craig-Hallum downgraded the stock from Buy to Hold and lowered its price target from $35 to $15.
    • Camber Energy, Inc. (NYSE:CEI) fell 8.9% to close at $0.8298 after dropping more than 10% on Thursday.
    • Genfit SA (NASDAQ:GNFT) shares fell 8.3% to close at $3.75.
    Get the next $ALVR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALVR
    $AMPE
    $AMYT
    $ATEN

    CompanyDatePrice TargetRatingAnalyst
    A10 Networks Inc.
    $ATEN
    4/20/2026$24.00Buy → Neutral
    Sidoti
    Intuitive Surgical Inc.
    $ISRG
    3/11/2026$590.00Neutral → Buy
    Citigroup
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    Globus Medical Inc.
    $GMED
    1/30/2026$112.00Hold → Buy
    Needham
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    Intuitive Surgical Inc.
    $ISRG
    1/27/2026$660.00Buy
    TD Cowen
    Globus Medical Inc.
    $GMED
    1/27/2026$110.00Buy
    TD Cowen
    Universal Health Services Inc.
    $UHS
    1/7/2026$235.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    A10 Networks downgraded by Sidoti with a new price target

    Sidoti downgraded A10 Networks from Buy to Neutral and set a new price target of $24.00

    4/20/26 8:22:35 AM ET
    $ATEN
    Computer Communications Equipment
    Telecommunications

    Intuitive Surgical upgraded by Citigroup with a new price target

    Citigroup upgraded Intuitive Surgical from Neutral to Buy and set a new price target of $590.00

    3/11/26 8:28:54 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    Lake Street initiated coverage on Plus Therapeutics with a new price target

    Lake Street initiated coverage of Plus Therapeutics with a rating of Buy and set a new price target of $2.00

    2/3/26 8:52:26 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Olin John A bought $427,410 worth of shares (3,000 units at $142.47), increasing direct ownership by 938% to 3,320 units (SEC Form 4)

    4 - HERC HOLDINGS INC (0001364479) (Issuer)

    3/2/26 4:12:37 PM ET
    $HRI
    Misc Corporate Leasing Services
    Industrials

    Director Maclin Todd bought $1,041,467 worth of shares (10,000 units at $104.15) (SEC Form 4)

    4 - KIMBERLY CLARK CORP (0000055785) (Issuer)

    2/9/26 4:23:13 PM ET
    $KMB
    Containers/Packaging
    Consumer Discretionary

    Director Maclin Todd transferred by will 134 shares) and bought $38,775 worth of shares (266 units at $145.77), increasing direct ownership by 20% to 2,400 units (SEC Form 4)

    4 - KIMBERLY CLARK CORP (0000055785) (Issuer)

    2/6/26 5:27:22 PM ET
    $KMB
    Containers/Packaging
    Consumer Discretionary

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Chung Peter Y was granted 7,233 shares (SEC Form 4)

    4 - A10 Networks, Inc. (0001580808) (Issuer)

    4/24/26 4:03:48 PM ET
    $ATEN
    Computer Communications Equipment
    Telecommunications

    Director Wolf Dana Elizabeth was granted 7,233 shares, increasing direct ownership by 14% to 60,061 units (SEC Form 4)

    4 - A10 Networks, Inc. (0001580808) (Issuer)

    4/23/26 4:22:35 PM ET
    $ATEN
    Computer Communications Equipment
    Telecommunications

    Director Singer Eric was granted 7,233 shares, increasing direct ownership by 8% to 93,504 units (SEC Form 4)

    4 - A10 Networks, Inc. (0001580808) (Issuer)

    4/23/26 4:21:16 PM ET
    $ATEN
    Computer Communications Equipment
    Telecommunications

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HCA Healthcare Reports First Quarter 2026 Results

    HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2026. Key first quarter metrics (all percentage changes compare 1Q 2026 to 1Q 2025 unless otherwise noted): Revenues increased 4.3 percent to $19.109 billion Net income attributable to HCA Healthcare, Inc. increased 0.6 percent to $1.620 billion Diluted earnings per share and diluted earnings per share, as adjusted, increased 10.9 percent to $7.15 per diluted share Adjusted EBITDA increased 1.9 percent to $3.802 billion Cash flows from operating activities increased 22.0 percent to $2.014 billion Same facility admissions increased 0.9 percent and same fac

    4/24/26 7:00:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    Corsair Gaming to Report First Quarter 2026 Financial Results on May 7

    Corsair Gaming, Inc. (NASDAQ:CRSR) ("Corsair" or the "Company"), a leading global provider and innovator of high-performance products for gamers, streamers, content-creators, gaming PC builders, and SIM Racing enthusiasts, today announced it will release its first quarter 2026 results and financial outlook after the Nasdaq close on Thursday, May 7, 2026, with its management hosting a conference call to discuss results at 2:00 p.m. Pacific Time that same day. The 2:00 p.m. Pacific Time conference call will be accessible on Corsair's Investor Relations website at https://ir.corsair.com, or by dialing 1-844-676-2245 (USA) or 1-412-634-6652 (International) with conference ID 10207948. A repla

    4/23/26 4:00:00 PM ET
    $CRSR
    Computer peripheral equipment
    Technology

    Cuentas Inc. Reports 2025 Strategic Transformation, Cuts Annual Net Loss by more than 50%, Streamlines Legacy Liabilities, and Expands World Mobile Alliance

    Miami Beach, FL, April 23, 2026 (GLOBE NEWSWIRE) -- Cuentas Inc. (OTCQB:CUEN) today announced a pivotal year of strategic transformation in connection with its Annual Report on Form 10-K for the year ended December 31, 2025, highlighted by a reduction in annual net loss of 52.5%, significant progress in resolving legacy liabilities, and continued expansion of its high-potential alliance with World Mobile Group Ltd. During 2025, Cuentas sharpened its focus around its mobile communications platform and executed a series of transactions designed to strengthen its operating foundation, simplify its balance sheet, and accelerate long-term strategic positioning. The Company believes these acti

    4/23/26 8:27:11 AM ET
    $CUEN
    Computer Software: Prepackaged Software
    Technology

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    SEC Filings

    View All

    SEC Form DEFA14A filed by Globus Medical Inc.

    DEFA14A - GLOBUS MEDICAL INC (0001237831) (Filer)

    4/24/26 4:06:06 PM ET
    $GMED
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by Globus Medical Inc.

    DEF 14A - GLOBUS MEDICAL INC (0001237831) (Filer)

    4/24/26 4:04:33 PM ET
    $GMED
    Medical/Dental Instruments
    Health Care

    Universal Health Services Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - UNIVERSAL HEALTH SERVICES INC (0000352915) (Filer)

    4/24/26 8:15:17 AM ET
    $UHS
    Hospital/Nursing Management
    Health Care

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Financials

    Live finance-specific insights

    View All

    HCA Healthcare Reports First Quarter 2026 Results

    HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2026. Key first quarter metrics (all percentage changes compare 1Q 2026 to 1Q 2025 unless otherwise noted): Revenues increased 4.3 percent to $19.109 billion Net income attributable to HCA Healthcare, Inc. increased 0.6 percent to $1.620 billion Diluted earnings per share and diluted earnings per share, as adjusted, increased 10.9 percent to $7.15 per diluted share Adjusted EBITDA increased 1.9 percent to $3.802 billion Cash flows from operating activities increased 22.0 percent to $2.014 billion Same facility admissions increased 0.9 percent and same fac

    4/24/26 7:00:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    Corsair Gaming to Report First Quarter 2026 Financial Results on May 7

    Corsair Gaming, Inc. (NASDAQ:CRSR) ("Corsair" or the "Company"), a leading global provider and innovator of high-performance products for gamers, streamers, content-creators, gaming PC builders, and SIM Racing enthusiasts, today announced it will release its first quarter 2026 results and financial outlook after the Nasdaq close on Thursday, May 7, 2026, with its management hosting a conference call to discuss results at 2:00 p.m. Pacific Time that same day. The 2:00 p.m. Pacific Time conference call will be accessible on Corsair's Investor Relations website at https://ir.corsair.com, or by dialing 1-844-676-2245 (USA) or 1-412-634-6652 (International) with conference ID 10207948. A repla

    4/23/26 4:00:00 PM ET
    $CRSR
    Computer peripheral equipment
    Technology

    Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

    HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announced today the initiation of manufacturing activities and technology transfer with SpectronRx under a previously executed Master Services Agreement (MSA), in support of late-stage clinical manufacturing of Rhenium-186 and REYOBIQ. With SpectronRx serving as a second GMP manufacturing site alongside Radiomedix, and Rhenium-186 isotope supplied through Telix Pharmaceuticals, Plus strengthens the reliability of its multi-partner supply chain

    4/23/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BREXAFEMME issued to SCYNEXIS, INC

    Submission status for SCYNEXIS, INC's drug BREXAFEMME (ORIG-1) with active ingredient IBREXAFUNGERP has changed to 'Approval' on 06/01/2021. Application Category: NDA, Application Number: 214900, Application Classification: Type 1 - New Molecular Entity

    6/2/21 11:20:46 AM ET
    $SCYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BREXAFEMME issued to SCYNEXIS, INC

    Submission status for SCYNEXIS, INC's drug BREXAFEMME (SUPPL-1) with active ingredient IBREXAFUNGERP has changed to 'Approval' on 06/01/2021. Application Category: NDA, Application Number: 214900, Application Classification: Type 1 - New Molecular Entity

    6/2/21 9:57:42 AM ET
    $SCYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for POSIMIR

    Submission status for DURECT CORP's drug POSIMIR (ORIG-1) with active ingredient BUPIVACAINE has changed to 'Approval' on 02/01/2021. Application Category: NDA, Application Number: 204803, Application Classification: Type 3 - New Dosage Form

    2/2/21 7:24:30 AM ET
    $DRRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:53:36 PM ET
    $NC
    Coal Mining
    Energy

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:38:59 PM ET
    $NC
    Coal Mining
    Energy

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:38:47 PM ET
    $NC
    Coal Mining
    Energy

    $ALVR
    $AMPE
    $AMYT
    $ATEN
    Leadership Updates

    Live Leadership Updates

    View All

    Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    HOUSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces that it has granted inducement awards to Eric J Daniels, M.D., its new Chief Development Officer who joined the Company on April 20, 2026. The awards were granted on April 20, 2026 under the Company's 2015 New Employee Incentive Plan, as amended, which provides for the granting of equity awards to new employees as an inducement to join the Company. The inducement awards consist of options to purchase 20,000 shares of the Company common

    4/22/26 4:30:00 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution

    HOUSTON, April 15, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, announces the appointment of Randy H. Goodman, Ph.D., M.H.A., as Vice President, Value Strategy & Health Economics and Outcomes Research (HEOR), effective April 13th, 2026. Dr. Goodman is a highly experienced health economics and market access leader with more than 20 years of experience spanning global pricing and reimbursement strategy, real-world evidence generation, and value-based healthcare modeling across the biotechnology, pharmaceutic

    4/15/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline

    HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announced the appointment of Eric J. Daniels, M.D., MBA, as Chief Development Officer, effective April 20, 2026. Dr. Daniels is a seasoned biotechnology executive with more than two decades of experience spanning clinical development, regulatory strategy, corporate operations, and business development. He most recently served as Chief Development Officer at Kiora Pharmaceuticals , where he oversaw the company's full development portfolio

    4/9/26 7:30:00 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care